Stockreport

Alexion Pharmaceuticals to Initiate Phase 3 Study for Ultomiris as a Potential Coronavirus Treatment [The Motley Fool]

Alexion Pharmaceuticals, Inc  (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations
PDF Alexion Pharmaceuticals(NASDAQ:ALXNThis study, which is set to start in May, will enroll about 70 patients in several countries that have been severely impacted by the o [Read more]